Journal article
Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis
American journal of ophthalmology, Vol.132(4), pp.463-471
10/01/2001
DOI: 10.1016/s0002-9394(01)01209-0
PMID: 11589865
Abstract
PURPOSE: To evaluate the effect of treatment with interferon β-1a (Avonex) initiated at the time of a first episode of optic neuritis in patients at high risk for multiple sclerosis (MS).
Details
- Title: Subtitle
- Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis
- Creators
- CHAMPS Study Group
- Contributors
- Michael Wall (Contributor) - University of Iowa, Ophthalmology and Visual Sciences
- Resource Type
- Journal article
- Publication Details
- American journal of ophthalmology, Vol.132(4), pp.463-471
- Publisher
- Elsevier B.V
- DOI
- 10.1016/s0002-9394(01)01209-0
- PMID
- 11589865
- ISSN
- 0002-9394
- eISSN
- 1879-1891
- Language
- English
- Date published
- 10/01/2001
- Description audience
- Professional
- Academic Unit
- Neurology; Ophthalmology and Visual Sciences
- Record Identifier
- 9983980037502771
Metrics
13 Record Views